31Jul
Department of Justice fines pharmaceutical company
Compliance Today (August 2020) - On May 7, the Department of Justice’s Antitrust Division announced a deferred prosecution agreement, in which Apotex Corp. agreed to pay a $24.1 million criminal penalty for price-fixing. The Florida-based company conspired with competitors to increase and maintain the price of pravastatin, a commonly prescribed cholesterol medication that lowers the risk of heart disease and stroke....
By:
Health Care Compliance Association (HCCA)
Related
As if wading through the NAICS codes to complete the Hart-Scott-Rodino form’s Item 5 wasn’t exciti...
Read More >
Australia requires a wide variety of investments by foreign businesses to be reviewed and approved b...
Read More >
Recently, Illinois amended its Equal Pay Act to include a ban on salary-history inquiries, with the ...
Read More >
On December 20, 2019, President Trump signed into law the Setting Every Community Up for Retirement ...
Read More >
Section 220 of the Delaware General Corporation Law affords stockholders a qualified right to inspec...
Read More >
In a recent decision, released June 19, 2019, the Ontario Court of Appeal reversed a 2018 decision i...
Read More >